Compare Dr. Reddys with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB AUROBINDO PHARMA DR. REDDYS LAB/
AUROBINDO PHARMA
 
P/E (TTM) x 47.4 10.5 452.1% View Chart
P/BV x 5.1 3.4 153.3% View Chart
Dividend Yield % 0.5 0.3 148.1%  

Financials

 DR. REDDYS LAB   AUROBINDO PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-21
AUROBINDO PHARMA
Mar-20
DR. REDDYS LAB/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs5,515838 658.1%   
Low Rs3,028281 1,076.8%   
Sales per share (Unadj.) Rs1,145.4394.2 290.5%  
Earnings per share (Unadj.) Rs114.548.5 235.8%  
Cash flow per share (Unadj.) Rs188.465.0 289.6%  
Dividends per share (Unadj.) Rs25.003.00 833.3%  
Dividend yield (eoy) %0.60.5 109.2%  
Book value per share (Unadj.) Rs1,053.2286.9 367.1%  
Shares outstanding (eoy) m166.30585.93 28.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.71.4 262.7%   
Avg P/E ratio x37.311.5 323.7%  
P/CF ratio (eoy) x22.78.6 263.6%  
Price / Book Value ratio x4.12.0 207.9%  
Dividend payout %21.86.2 353.4%   
Avg Mkt Cap Rs m710,289327,872 216.6%   
No. of employees `000NANA-   
Total wages/salary Rs m36,29932,192 112.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m190,475230,985 82.5%  
Other income Rs m2,9141,919 151.9%   
Total revenues Rs m193,389232,904 83.0%   
Gross profit Rs m38,69948,382 80.0%  
Depreciation Rs m12,2889,667 127.1%   
Interest Rs m9703,051 31.8%   
Profit before tax Rs m28,35537,582 75.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3199,135 102.0%   
Profit after tax Rs m19,03628,447 66.9%  
Gross profit margin %20.320.9 97.0%  
Effective tax rate %32.924.3 135.2%   
Net profit margin %10.012.3 81.1%  
BALANCE SHEET DATA
Current assets Rs m145,503164,125 88.7%   
Current liabilities Rs m81,038113,868 71.2%   
Net working cap to sales %33.821.8 155.5%  
Current ratio x1.81.4 124.6%  
Inventory Days Days6115 401.0%  
Debtors Days Days9568 139.5%  
Net fixed assets Rs m109,979123,507 89.0%   
Share capital Rs m832586 142.0%   
"Free" reserves Rs m174,319167,518 104.1%   
Net worth Rs m175,151168,104 104.2%   
Long term debt Rs m6,2990-   
Total assets Rs m255,482287,632 88.8%  
Interest coverage x30.213.3 227.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.8 92.8%   
Return on assets %7.811.0 71.5%  
Return on equity %10.916.9 64.2%  
Return on capital %16.224.2 66.9%  
Exports to sales %51.346.4 110.6%   
Imports to sales %18.115.1 119.6%   
Exports (fob) Rs m97,699107,126 91.2%   
Imports (cif) Rs m34,42034,902 98.6%   
Fx inflow Rs m97,699107,445 90.9%   
Fx outflow Rs m34,42038,991 88.3%   
Net fx Rs m63,27968,454 92.4%   
CASH FLOW
From Operations Rs m35,70343,813 81.5%  
From Investments Rs m-22,660-15,676 144.5%  
From Financial Activity Rs m-298-19,472 1.5%  
Net Cashflow Rs m12,8588,712 147.6%  

Share Holding

Indian Promoters % 26.7 48.9 54.7%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 43.9 37.6 116.8%  
FIIs % 29.0 24.4 119.1%  
ADR/GDR % 12.2 0.0 -  
Free float % 61.0 48.1 126.9%  
Shareholders   221,107 232,634 95.0%  
Pledged promoter(s) holding % 0.0 24.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   PROCTER & GAMBLE HEALTH  COLINZ LABOR  ADESHWAR MEDITEX  HESTER BIOSCIENCES  CIPLA  



Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage(Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors(Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC(Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend(Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today(Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jul 23, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - LAURUS LABS COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS